Ignite Creation Date:
2025-12-24 @ 5:32 PM
Ignite Modification Date:
2026-01-02 @ 4:13 PM
Study NCT ID:
NCT00610168
Status:
COMPLETED
Last Update Posted:
2018-06-06
First Post:
2008-01-25
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination.
Sponsor:
GlaxoSmithKline
Organization:
Study Overview
Official Title:
Evaluation of GSK Biologicals' dTpa Booster Vaccine in Young Adults 10 Years After Previous dTpa Boosting.
Status:
COMPLETED
Status Verified Date:
2017-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to assess the efficacy and safety of repeating dTpa booster in adults 10 years after previous booster vaccination with dTpa in a prior clinical study. Only subjects who received booster vaccination in the previous clinical study are eligible for participation in this study.
Detailed Description:
This Protocol Posting has been updated in order to comply with FDA AA, Sep 2007.
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: